Know Your Myeloma Therapy: Carfilzomib (Kyprolis) with Dr. Harsh Parmar
Learn about carfilzomib (Kyprolis) with Dr. Harsh Parmar from Hackensack. What's its mechanism of action? What is it usually combined with? What are the usual side effects and how can we combat these? What clinical trials are telling us more about the use and effects of carfilzomib?
Come with your questions.
Audrey Burton-Bethke
Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.
Dr. Harsh Parmar
Dr. Harsh V Parmar is a Medical Oncology Specialist in Hackensack, New Jersey. He graduated with honors in 2012. Having more than 9 years of diverse experiences, especially in MEDICAL ONCOLOGY, Dr. Harsh V Parmar affiliates with many hospitals including Hackensack University Medical Center